Revisiting Cancer Diagnosis in Scotland: Further Insights from the Second Scottish National Cancer Diagnosis Audit

Table 6

Primary care intervals and diagnostic intervals where the interval was greater than 60 and 90 days, respectively, for both time periods (excluding screen detected).

	% PCI >60 days		% PCI >90 days		PCI valid N		% DI >60 days		% DI >90 days		DI valid N
	2014	2019	2014	2019	2014	2019	2014	2019	2014	2019	2014	2019
Total	11.3	10.9	7.7	7.5	1314	1523	28.3	24.5	17.8	16.2	1572	1711
Sex
Male	12.5	11.3	8.2	7.4	656	761	31.5	28.2	19.3	19.2	791	854
Female	10.2	10.5	7.1	7.6	658	762	25.1	20.9	16.3	13.2	781	857
Age categories (years)
0–24	n < 5	n < 5	n < 5	n < 5	7	19	n < 5	n < 5	n < 5	n < 5	11	22
25–49	8.9	12.0	5.6	7.0	124	158	23.7	20.5	12.5	11.9	152	176
50–64	12.7	10.3	9.3	7.3	332	400	30.8	23.2	20.8	13.2	390	440
65–74	12.0	11.7	8.5	8.3	376	470	32.4	27.8	20.2	20.5	445	518
75–84	11.2	9.4	6.3	6.4	348	362	25.5	22.2	16.2	13.6	408	418
≥85	8.7	14.9	6.3	10.5	127	114	22.3	30.7	13.3	24.8	166	137
Cancer site categories
Colon	12.2	14.6	9.2	11.4	98	123	32.1	31.5	22.1	21.7	131	143
Lung and bronchus	17.2	9.3	9.0	5.3	221	227	28.3	18.7	18.9	11.5	286	278
Breast	n < 5	5.3	1.2	4.3	173	187	5.9	7.8	2.7	4.2	188	192
Prostate	13.8	12.6	11.9	8.9	160	214	48.0	36.7	28.6	27.5	175	218
Comorbidity category
None	10.2	10.2	7.6	7.8	315	421	28.5	22.2	17.1	13.6	369	455
1	10.0	11.6	6.8	6.8	370	457	25.0	24.0	16.6	16.0	440	525
2	9.8	10.0	5.3	6.6	337	331	27.0	21.6	15.1	14.9	404	370
≥3	16.4	11.9	11.9	8.9	286	302	34.2	31.3	23.6	21.0	351	348
Patient SIMD at diagnosis
1	10.1	8.8	8.0	4.0	286	273	26.0	23.2	17.2	11.1	354	314
2	10.0	9.0	6.3	5.9	240	288	28.7	22.7	16.9	16.1	296	330
3	10.2	14.0	7.6	9.7	225	299	26.2	26.2	17.9	19.4	263	340
4	13.4	11.2	7.3	8.7	314	286	31.6	25.2	19.3	14.5	358	318
5	12.4	11.4	9.2	8.7	249	368	28.6	25.8	17.6	19.2	301	396
2-fold urban rural classification
Urban	10.7	10.2	7.1	6.7	987	1172	27.4	23.8	17.0	15.7	1191	1322
Rural	13.1	13.9	9.5	10.3	327	339	31.2	28.0	20.2	18.6	381	371